Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk

Molecular Carcinogenesis

Volumn 49, Issue 9, 2010, Pages 805-809

  Knechtel, Gudrun ^a   Szkandera, Joanna ^a   Stotz, Michael ^a   Hofmann, Günter ^a   Langsenlehner, Uwe ^b   Krippl, Peter ^c   Samonigg, Hellmut ^a   Renner, Wilfried ^a   Langner, Cord ^a   Dehchamani, Dadbeh ^a   Gerger, Armin ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Internal Outpatient Department   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Colorectal cancer; Hypoxia inducible factor 1; Polymorphism; Risk

Indexed keywords

CD31 ANTIGEN; EXONUCLEASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCLONAL ANTIBODY; HYPOXIA INDUCIBLE FACTOR 1;

ADULT; AGED; ALLELE; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER RISK; CANCER SIZE; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SECTION; COLORECTAL TUMOR; EUROPE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; MIDDLE AGED; RISK;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EUROPE; FEMALE; GENOTYPE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 77956198446     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20655     Document Type: Article

References (24)

1. Midgley R, Kerr D. Colorectal cancer. Lancet 1999;353:391-399.
2. Burt RW, DiSario JA, Cannon-Albright L. Genetics of colon cancer: Impact of inheritance on colon cancer risk. Annu Rev Med 1995;46:371-379.
3. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review. Gastroenterology 1993;104:1535-1549.
4. Ponz deLeon M, Sassatelli R, Benatti P, Roncucci L. Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry. Cancer 1993;71:3493-3501.
5. Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990;113:373-384.
6. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med 1990;323:1228-1233. (Pubitemid 20366527)
7. Gillen CD, Walmseley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: A comparison of the colorectal cancer risk in extensive colitis. Gut 1994;35:1590-1592. (Pubitemid 24339258)
8. Cho E, Smith-Warner SA, Ritz J, et al. Alcohol intake and colorectal cancer: A pooled analysis of 8 cohort studiers. Ann Intern Med 2004;140:603-613.
9. Botteri E, Iodice S, Bagnardi V, Raimond S, Lowenfels AB, Maisonneuve P. Smoking and Colorectal Cancer: A meta-analysis. JAMA 2008;300:2765-2778.
10. Dube C, Rostom A, Lewis G, et al. The use of aspirin for primary prevention of colorectal cancer: A systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007;146:365-375.
11. Rannala B. Finding genes influencing susceptibility to complex diseases in the post-genome era. Am J Pharmacogenomics 2001;1:203-221.
12. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxiainducible factor 1. Annu Rev Cell Dev Biol 1999;15:551-578.
13. Zhong H, Semenza GL, Simons JW, De Marzo AM. Upregulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev 2004;28:88-93. (Pubitemid 38448745)
14. Tanimoto K, Yoshiga K, Eguchi H, et al. Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 2003;24:1779-1783.
15. Ryan HE, Poloni M, McNulty W, et al. Hypoxia-inducible factor-1 is a positive factor in solid tumor growth. Cancer Res 2000;60:4010-4015.
16. Chau CH, Permeter MG, Steinberg SM, et al. Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer. Cancer Biol Ther 2005;4:1222-1225.
17. Kim HO, Jo YH, Lee J, Lee SS, Yoon KS. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer. Oncol Rep 2008;20:1181-1187.
18. Ollerenshaw M, Page T, Hammonds J, Demaine A. Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet 2004;153:122-126. (Pubitemid 39592144)
19. Kuwai T, Kitadai Y, Tanaka S, et al. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. Oncol Rep 2004;12:1033-1037.
20. Fransén K, Fenech M, Fredrikson M, Dabrosin C, Söderkvist P. Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol Carcinog 2006;45:833-840.
21. Hasan J, Byers R, Jayson GC. Intra-tumoral microvessel density in human solid tumours. Br J Cancer 2002;86:1566-1577. (Pubitemid 34628110)
22. Naidu R, Har YC, Taib NA. Associations between hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms and risk of developing breast cancer. Arch Med Res 2009;56:441-447.
23. Apaydin I, Konac E, Onen HI, Akbaba M, Tekin E, Ekmekci A. Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer. Neoplasma 2008;39:338-345.
24. Muñoz-Guerra MF, Fernández-Contreras ME, Moreno AL, Martín ID, Herráez B, Gamallo C. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol 2009;16:2351-2358.